tirzepatide application What Is Used for? Approved and Potential Uses Tirzepatide Intake Forms | GLP-1

Pfizer is developing a long-acting GLP-1 drug that could compete directly with Eli Lilly's Mounjaro and Zepbound when it reaches the Canadian market.

The GLP1-RAs vs sodium-glucose cotransporter-2 (SGLT-2) inhibitors cohort included new users of GLP-1 RAs (n=83,464) or SGLT-2 inhibitors (n=78,366), and the GLP1-RAs vs dipeptidyl peptidase-4 (DPP-4) inhibitors cohort included new users of GLP-1 RAs (n=108,322) or DPP-4 inhibitors (n=55,411)

Sugar Free

Starting Thursday, the Food and Drug Administration will crack down on outsourcing facilities that make or distribute compounded alternatives to brand-name Ozempic and Wegovy.

Tirzepatide is a synthetic 39-amino acid peptide and dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor